Manulife US REIT Completes US\$92.5 Million Sale of Figueroa, Signals Strategic Shift
Key Developments
- Major Asset Sale: Manulife US Real Estate Investment Trust (“MUST”) has completed the divestment of Figueroa, a 35-storey Class A office building in downtown Los Angeles, for US\$92.5 million to a municipal entity. Net proceeds of approximately US\$82 million will be used primarily for debt repayment due in 2026 and partial repayment of 2027 loans.
- Debt Reduction and Liquidity Improvement: The sale, along with previous divestments (Capitol, Plaza, Peachtree), enables MUST to hit its Minimum Sale Target of US\$328.7 million under the Master Restructuring Agreement (MRA) with lenders, strengthening liquidity and potentially paving the way for an exit from the MRA.
- Debt Repayment Details: Since November 2024, MUST has repaid about US\$316.7 million of debt, largely through asset sales and balance sheet cash. Following the Figueroa transaction, the REIT will further repay US\$35.6 million (2026 debt) and US\$36.8 million (2027 debt), leaving only US\$133.4 million of loans outstanding for 2027.
- Portfolio and Financial Metrics Improvement: Assuming US\$72.4 million of proceeds are used for debt repayment and US\$10 million for capital expenditure, aggregate leverage improves from ~58% to ~55%, weighted average debt maturity rises from 2.1 years to 2.3 years, and portfolio occupancy jumps from 67.6% to 73.2% (pro forma as of 31 March 2026).
Strategic Priorities and Growth Plans
- Exit from MRA: MUST’s management is in discussions with lenders about exiting the MRA, which, if achieved, would allow the REIT to resume distributions in a disciplined and sustainable manner.
- Distribution Resumption: The Manager intends to progressively resume distributions upon a successful exit from the MRA, with a focus on sustainability and aligning bank interest coverage ratios with Monetary Authority of Singapore’s guidelines (1.5 times).
- Growth and Value Up Plan: The Manager will execute the Growth and Value Up Plan, approved in December 2025, aiming to reposition the portfolio and drive long-term value for unitholders. The broadened investment mandate enables MUST to diversify into more resilient and less capital-intensive sectors, such as industrial, living sector (residential), and retail properties across the U.S. and Canada, with up to US\$600 million of acquisitions beyond US office assets.
- 2027 Debt Management: Remaining debt maturities in 2027 will be addressed through strategies like further divestments, refinancing, equity raising, or debt maturity extensions.
Shareholder & Price Sensitive Information
- Distribution Suspension and Potential Resumption: Investors should note that distributions have been suspended but may resume if MUST exits the MRA. This is a significant event that could impact unit prices and investor sentiment.
- Debt Reduction and Financial Stability: The rapid reduction in leverage and improved portfolio metrics enhance MUST’s financial stability, which could positively affect share price.
- Portfolio Diversification: The ability to invest in non-office sectors gives MUST flexibility to adapt to the challenging U.S. office sector environment, potentially reducing risk and increasing future returns.
- Asset Sales and Liquidity: The completion of asset sales and repayment of debt are critical milestones in stabilizing the REIT’s balance sheet and restoring lender confidence.
Background
MUST is the first pure-play U.S. office REIT listed in Asia, with a portfolio of seven freehold office properties totaling 3.5 million sq ft across Arizona, California, Georgia, New Jersey, Virginia, and Washington D.C. The Sponsor, The Manufacturers Life Insurance Company (“Manulife”), is a leading Canada-based financial services group with global operations, providing insurance, wealth management, and asset management services. The Manager, Manulife US Real Estate Management Pte. Ltd., is wholly owned by the Sponsor and aims to deliver sustainable distributions and risk-adjusted returns to unitholders.
Investor Implications
The completion of the Figueroa sale and subsequent debt repayment represent decisive steps in MUST’s turnaround, with potential for positive share price movement as financial metrics improve and the distribution outlook brightens. The strategic expansion into new property sectors may further enhance future growth prospects.
Disclaimer
IMPORTANT: This article is for informational purposes only and does not constitute an offer or solicitation to purchase or subscribe for securities of Manulife US REIT. Investments in REITs involve risks, including possible loss of principal. Past performance is not indicative of future results. Please consult your financial advisor before making investment decisions.
满怀信心：Manulife US REIT 完成 Figueroa 大楼出售，战略转型信号明确
主要进展
- 重大资产出售： Manulife US 房地产投资信托（“MUST”）已完成洛杉矶市中心 35 层甲级写字楼 Figueroa 的出售，售价为 9,250 万美元，买家为市政实体。约 8,200 万美元净收益主要用于偿还 2026 年到期贷款及部分 2027 年贷款。
- 债务削减与流动性提升： 此次出售连同之前的资产处置（Capitol、Plaza、Peachtree）帮助 MUST 达到与贷款方签署的“主重组协议（MRA）”规定的最低出售目标 3.287 亿美元，显著提升流动性，为退出 MRA 打下基础。
- 债务偿还细节： 自 2024 年 11 月以来，MUST 已通过资产出售及现金偿还约 3.167 亿美元债务。Figueroa 交易后将进一步偿还 3,560 万美元（2026 债务）及 3,680 万美元（2027 债务），2027 年剩余贷款仅有 1.334 亿美元。
- 财务指标改善： 假定 7,240 万美元用于偿债，1,000 万美元用于资本支出，杠杆率将从约 58%降至 55%，加权平均债务到期从 2.1 年升至 2.3 年，组合出租率从 67.6%升至 73.2%（截至2026年3月31日的模拟数据）。
战略重点与增长计划
- 退出MRA： 管理层正与贷款方探讨退出 MRA 的后续计划，如成功退出，将恢复分派，且强调可持续性。
- 分派恢复： 管理层计划在退出 MRA 后逐步恢复分派，并将银行利息覆盖率与新加坡金融管理局现行标准（1.5倍）对齐。
- 成长与价值提升计划： 管理层将执行2025年12月获股东批准的“成长与价值提升计划”，投资范围扩大，可在美国和加拿大工业、生活（住宅）和零售物业领域进行高达6亿美元的收购，降低对美国办公资产的依赖。
- 2027年债务管理： 剩余债务将通过资产出售、再融资、股权筹集或延长期限等策略解决。
股东与价格敏感信息
- 分派暂停与可能恢复： 投资者需注意，目前分派暂停，但若成功退出MRA将逐步恢复，这将显著影响价格与市场情绪。
- 债务削减与财务稳定： 杠杆率迅速下降、财务指标改善，有望增强价格表现与投资者信心。
- 投资组合多元化： 新投资授权使 MUST 能适应美国办公市场挑战，降低风险、提升未来回报。
- 资产出售与流动性： 资产出售与偿债是稳定资产负债表、恢复贷款方信心的重要里程碑。
背景介绍
MUST 是亚洲首个专注于美国办公楼的上市 REIT，资产组合为七座永久产权办公楼，分布于亚利桑那、加利福尼亚、佐治亚、新泽西、弗吉尼亚及华盛顿特区，总可出租面积 350 万平方英尺。赞助商“加拿大人寿保险公司”是全球领先金融集团，管理人 Manulife US Real Estate Management Pte. Ltd. 由赞助商全资控股，致力于为持有人带来可持续分派及风险回报。
投资者影响
Figueroa 大楼出售及后续偿债，是 MUST 转型的关键步骤，财务指标改善及分派恢复预期，有望推升价格，战略扩展新领域亦将增强未来增长前景。
免责声明
重要提示： 本文仅供参考，不构成购买或认购 Manulife US REIT 证券的邀约或要约。投资 REIT 存在风险，包括本金损失。过往业绩不代表未来表现。请在投资前咨询专业顾问。
